Edition:
United Kingdom

Erytech Pharma SA (ERYP.PA)

ERYP.PA on Paris Stock Exchange

6.47EUR
2:47pm GMT
Change (% chg)

€-0.01 (-0.15%)
Prev Close
€6.49
Open
€6.49
Day's High
€6.70
Day's Low
€6.24
Volume
54,969
Avg. Vol
47,091
52-wk High
€19.57
52-wk Low
€5.92

Chart for

About

Erytech Pharma SA, also known as ERYTECH Pharma, is a France-based biopharmaceutical company developing medicinal products mainly in oncology, hematology and immunology fields of business. The Company offers ESY-ASP (GRASPA), a medicinal product consisting of L-Asparaginase entrapped into human homologous red blood cells. The... (more)

Overall

Beta: 0.86
Market Cap(Mil.): €284.01
Shares Outstanding(Mil.): 11.74
Dividend: --
Yield (%): --

Financials

  ERYP.PA Industry Sector
P/E (TTM): -- 69.71 34.39
EPS (TTM): -3.20 -- --
ROI: -- 9.01 14.96
ROE: -- 10.15 16.52

BRIEF-ERYTECH Partners With New York Blood Center For Red Blood Cell Supply And Research

* NEW YORK BLOOD CENTER (NYBC)TO BECOME LONG-TERM SUPPLIER OF DONOR RED BLOOD CELLS (RBC) TO ERYTECH

16 Nov 2018

BRIEF-Erytech Pharma 9-Month Operating Loss Widens To 34.1 Million Euros

* ANNOUNCED ON MONDAY CASH POSITION OF EUR 146.9 MLN AS OF SEPT 30, 2018, COMPARED WITH EUR 185.5 MLN AS OF DEC 31, 2017

13 Nov 2018

Earnings vs. Estimates